Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

Data Collection Analysis Business Management200 enrolled

Overview

Increase surveillance for LYNCH Syndrome

The purpose of this minimal risk, observational survey is to increase surveillance for Lynch Syndrome (hereditary non-polyposis colon cancer), Colorectal, and Endometrial cancer, also to determine targeted risk-reducing and preventative strategies.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Colon Cancer Endometrial Cancer

Interventions

Genetic testingOTHER

LYNCH genetic testing

Eligibility

Sex: ALLMin age: 18 YearsMax age: 64 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Must be a Medical Practitioner * Medical Doctor (MD) * Doctor of Osteopathic (DO) * Physician Assistant (PA) * Advanced Practice Registered Nurse (APRN) * Nurse Practitioner (NP) * Must have a current standard operating procedure that includes obtaining/reviewing medical history and family medical history. Exclusion Criteria: * Government-funded insurance data cannot be included in the study.

Locations (1)

DCABM

Land O' Lakes, Florida, United States

Outcomes

Primary Outcomes

Provider Structures and Processes

Plan of Care Changes due to LYNCH genetic testing. Provider based observational survey system on the health and well-being of patients and populations

Time frame: 36 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.